Your session is about to expire
← Back to Search
CloSYS Ultra Sensitive Rinse mouthwash for Viral Diseases (AMPoL Trial)
Phase 2
Waitlist Available
Led By Stuart A Gansky, DrPH
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Tested positive for COVID-19 with a sample collected in the prior 7 days
Ability to read and speak English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 3 months
Awards & highlights
AMPoL Trial Summary
This trial will test the safety and effectiveness of different mouthwashes on people with COVID-19.
Eligible Conditions
- Viral Diseases
- COVID-19
- Coronavirus
- Pharyngitis
AMPoL Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowAMPoL Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in SARS-CoV-2 Viral Load
Secondary outcome measures
Any Hospitalization(s)
Self-reported Clinical Symptom(s)
Other outcome measures
Any Hospitalization(s) in Tobacco Users, Marijuana Smokers, or Vapers
Change in SARS-Cov-2 Viral Load in Tobacco Users, Marijuana Smokers, or Vapers
Change in Self-reported Clinical Symptom Onset in Tobacco Users, Marijuana Smokers, or Vapers
AMPoL Trial Design
5Treatment groups
Experimental Treatment
Placebo Group
Group I: Oral-B Mouth Sore (H2O2) mouthwashExperimental Treatment1 Intervention
Over the counter: Oral-B Mouth Sore (Oral-B, USA) contains hydrogen peroxide (H2O2)
Group II: Listerine MouthwashExperimental Treatment1 Intervention
Over the counter: Listerine Zero (Alcohol-Free)(Johnson and Johnson, USA) (C30H52O3)
Group III: Crest Pro-Health Multi-Protection (C21H38ClN) mouthwashExperimental Treatment1 Intervention
Over the counter: Crest Pro-Health Multi-Protection (Crest, USA) contains cetylpyridinium chloride (C21H38ClN)
Group IV: CloSYS (ClO2) mouthwashExperimental Treatment1 Intervention
Over the counter: CloSYS Ultra Sensitive Rinse (Rowpar Pharmaceutical Inc., USA) contains stabilized chlorine dioxide (ClO2)
Group V: Control (Distilled Water)Placebo Group1 Intervention
Over the counter: Distilled water
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,498 Previous Clinical Trials
11,936,294 Total Patients Enrolled
Rowpar Pharmaceuticals, Inc.Industry Sponsor
4 Previous Clinical Trials
316 Total Patients Enrolled
Stuart A Gansky, DrPHPrincipal InvestigatorProfessor and Lee Hysan Chair of Oral Epidemiology
2 Previous Clinical Trials
397 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger